CRCA vs. BAMU
CRCA (ProShares Ultra CRCL) and BAMU (Brookstone Ultra-Short Bond ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while BAMU is a Ultrashort Bond fund actively managed by Brookstone. Both are actively managed. At a correlation of -0.14, they often move in opposite directions. CRCA charges 0.95%/yr vs 1.09%/yr for BAMU.
Performance
CRCA vs. BAMU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -5.71% return, which is significantly lower than BAMU's 1.04% return.
CRCA
- 1D
- -7.63%
- 1M
- -8.37%
- YTD
- -5.71%
- 6M
- -7.07%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BAMU
- 1D
- 0.00%
- 1M
- 0.18%
- YTD
- 1.04%
- 6M
- 1.29%
- 1Y
- 2.97%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. BAMU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -5.71% | -81.81% |
BAMU Brookstone Ultra-Short Bond ETF | 1.04% | 1.31% |
Correlation
The correlation between CRCA and BAMU is -0.14, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | -0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. BAMU — Risk / Return Rank
CRCA
BAMU
CRCA vs. BAMU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Brookstone Ultra-Short Bond ETF (BAMU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | BAMU | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 5.03 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.45 | 4.14 | -4.59 |
Drawdowns
CRCA vs. BAMU - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than BAMU's maximum drawdown of -0.36%. Use the drawdown chart below to compare losses from any high point for CRCA and BAMU.
Loading charts...
Drawdown Indicators
| CRCA | BAMU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -0.36% | -93.66% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.12% | — |
Current DrawdownCurrent decline from peak | -84.81% | 0.00% | -84.81% |
Average DrawdownAverage peak-to-trough decline | -69.17% | -0.02% | -69.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.03% | — |
Volatility
CRCA vs. BAMU - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | BAMU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.07% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.43% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 195.93% | 0.59% | +195.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 195.93% | 0.87% | +195.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 195.93% | 0.87% | +195.06% |
CRCA vs. BAMU - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is lower than BAMU's 1.09% expense ratio.
Dividends
CRCA vs. BAMU - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 1.84%, less than BAMU's 3.06% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BAMU Brookstone Ultra-Short Bond ETF | 3.06% | 3.20% | 3.97% | 0.84% |
CRCA ProShares Ultra CRCL | 1.84% | 1.06% | 0.00% | 0.00% |
Frequently Asked Questions
CRCA and BAMU have a correlation of -0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CRCA is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA is cheaper with a 0.95% expense ratio, compared with 1.09% for BAMU.
BAMU has the higher dividend yield at 3.06%, compared with 1.84% for CRCA.
CRCA is categorized as Leveraged Equities, while BAMU is Ultrashort Bond. They also come from different issuers: ProShares and Brookstone. Their fees differ too: 0.95% for CRCA and 1.09% for BAMU.
Find the right allocation for CRCA and BAMU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer